Z-2267-2013 Class II Terminated
FDA device recall Z-2267-2013 was initiated by Microgenics Corp on Jul 23, 2013 and is designated Class II. Reason for recall: Surveillance of reagent stability for specific lots of DRI Cocaine Metabolite Reagent show an unexpected decreasing change in the reaction rate, indicating a faster than expected reagent degradation. The recall status is terminated (terminated Dec 2, 2013). Affected quantity: 1473 units in distribution.
Recall details
- Product Type
- Devices
- Report Date
- Oct 2, 2013
- Initiation Date
- Jul 23, 2013
- Termination Date
- Dec 2, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1473 units in distribution.
Product description
Reason for recall
Distribution pattern
US Distribution including the states of DC, MA, NJ, TX. FL, CA, WA, NY, TX, CT, KY, LA, AR, TN, AL, GA, CT, VA, NC, KS, MD, OH and IL
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2267-2013
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Microgenics Corp? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.